Literature DB >> 25614174

Pulmonary manifestations in adult patients with chronic granulomatous disease.

Hélène Salvator1, Nizar Mahlaoui2, Emilie Catherinot3, Elisabeth Rivaud3, Benoit Pilmis4, Raphael Borie5, Bruno Crestani5, Colas Tcherakian6, Felipe Suarez7, Bertrand Dunogue8, Marie-Anne Gougerot-Pocidalo9, Margarita Hurtado-Nedelec9, Jean-François Dreyfus10, Isabelle Durieu11, Fanny Fouyssac12, Olivier Hermine7, Olivier Lortholary13, Alain Fischer14, Louis-Jean Couderc6.   

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by failure of superoxide production in phagocytic cells. The disease is characterised by recurrent infections and inflammatory events, frequently affecting the lungs. Improvement of life expectancy now allows most patients to reach adulthood. We aimed to describe the pattern of pulmonary manifestations occurring during adulthood in CGD patients. This was a retrospective study of the French national cohort of adult patients (≥16 years old) with CGD. Medical data were obtained for 67 adult patients. Pulmonary manifestations affected two-thirds of adult patients. Their incidence was significantly higher than in childhood (mean annual rate 0.22 versus 0.07, p=0.01). Infectious risk persisted despite anti-infectious prophylaxis. Invasive fungal infections were frequent (0.11 per year per patient) and asymptomatic in 37% of the cases. They often required lung biopsy for diagnosis (10 out of 30). Noninfectious respiratory events concerned 28% of adult patients, frequently associated with a concomitant fungal infection (40%). They were more frequent in patients with the X-linked form of CGD. Immune-modulator therapies were required in most cases (70%). Respiratory manifestations are major complications of CGD in adulthood. Noninfectious pulmonary manifestations are as deleterious as infectious pneumonia. A specific respiratory monitoring is necessary.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25614174     DOI: 10.1183/09031936.00118414

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Response to the Letter to the Editor Regarding "Kinetics of Radiological Response of Thoracic Invasive Fungal Disease in Chronic Granulomatous Disease".

Authors:  Maria P Bondioni; Vassilios Lougaris; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2017-10-08       Impact factor: 8.317

2.  Kinetics of Radiological Response of Thoracic Invasive Fungal Disease in Chronic Granulomatous Disease.

Authors:  Romain Guery; Benjamin Subran; Arnaud Lefevre; Fanny Lanternier
Journal:  J Clin Immunol       Date:  2017-09-01       Impact factor: 8.317

Review 3.  Infectious Complications in Patients With Chronic Granulomatous Disease.

Authors:  Nicholas Bennett; Paul J Maglione; Benjamin L Wright; Christa Zerbe
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

4.  Late diagnosis of chronic granulomatous disease.

Authors:  T Barkai; R Somech; A Broides; R Gavrieli; B Wolach; N Marcus; D Hagin; T Stauber
Journal:  Clin Exp Immunol       Date:  2020-07-13       Impact factor: 4.330

5.  Respiratory Complications Lead to the Diagnosis of Chronic Granulomatous Disease in Two Adult Patients.

Authors:  Sylvie Colin de Verdière; Esther Noel; Claire Lozano; Emilie Catherinot; Mickael Martin; Elisabeth Rivaud; Louis-Jean Couderc; Hélène Salvator; Jacinta Bustamante; Thierry Martin
Journal:  J Clin Immunol       Date:  2017-01-27       Impact factor: 8.317

6.  Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry.

Authors:  Meera Patrawala; Ying Cui; Limin Peng; Ramsay L Fuleihan; Elizabeth K Garabedian; Kiran Patel; Lokesh Guglani
Journal:  J Clin Immunol       Date:  2020-01-09       Impact factor: 8.317

Review 7.  Imaging Features of Primary Immunodeficiency Disorders.

Authors:  Jose A Rodriguez; Tami J Bang; Carlos S Restrepo; Daniel B Green; Lorna P Browne; Daniel Vargas
Journal:  Radiol Cardiothorac Imaging       Date:  2021-03-25

8.  Early Identification of Lung Fungal Infections in Chronic Granulomatous Disease (CGD) Using Multidetector Computer Tomography.

Authors:  Maria Pia Bondioni; Vassilios Lougaris; Giuseppe Di Gaetano; Tiziana Lorenzini; Annarosa Soresina; Francesco Laffranchi; Diego Gatta; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2016-10-21       Impact factor: 8.317

9.  Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.

Authors:  Beatriz Morillo-Gutierrez; Rita Beier; Kanchan Rao; Lauri Burroughs; Ansgar Schulz; Anna-Maria Ewins; Brenda Gibson; Petr Sedlacek; Ladislav Krol; Brigitte Strahm; Irina Zaidman; Krzysztof Kalwak; Julie-An Talano; Ann Woolfrey; Chris Fraser; Isabelle Meyts; Ingo Müller; Jacek Wachowiak; Maria Ester Bernardo; Paul Veys; Karl-Walter Sykora; Andrew R Gennery; Mary Slatter
Journal:  Blood       Date:  2016-05-23       Impact factor: 22.113

10.  Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.

Authors:  Halil Tuna Akar; Saliha Esenboga; Deniz Cagdas; Sevil Oskay Halacli; Begum Ozbek; Karin van Leeuwen; Martin de Boer; Cagman Sun Tan; Yavuz Köker; Dirk Roos; Ilhan Tezcan
Journal:  J Clin Immunol       Date:  2021-02-24       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.